PERSONALIZED PHARMACOLOGICAL CORRECTION OF IMMUNE SYSTEMS, METABOLIC AND NEUROPSYCHIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA OF STAGE I AND II ON THE BACKGROUND OF HYPERTENSION DISEASE

The study aimed to develop a personalized pharmacological correction of immune, metabolic and neuropsychiatric disorders in chronic cerebral ischemia (CCI) stages I and II. The study included 104 patients, of which 76 were female and 28 were male, with CCI on the background of grade II hypertension,...

Full description

Saved in:
Bibliographic Details
Main Authors: A. I. Konoplya, A. A. Shulginova, N. A. Bystrova, V. P. Gavrilyuk, G. N. Ryzhikova
Format: article
Language:RU
Published: SPb RAACI 2021
Subjects:
Online Access:https://doaj.org/article/fff6df38d96e4e6fb50d431519ec5c22
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items